By examining the important signaling molecules linked to EGFR and PD-L1, results showed that PSP treatment significantly reduced the expression levels of p-EGFR(Tyr1068), c-Jun, STAT3, and p-STAT3(Tyr705) in colorectal cancer cells. This evidence concerns the gene EGFR and colorectal cancer.